Strategic Insights into the US$ 3.60 Billion Urokinase Market Opportunity
Expansion of emergency medical services and acute care facilities is strengthening demand for thrombolytic therapies. Urokinase continues to play an important role in managing life-threatening clot-related conditions. Strategic collaborations are supporting innovation and market reach.
Urokinase API Market to Hit US$ 3.60B by...